A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis

PHASE3CompletedINTERVENTIONAL
Enrollment

218

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

May 31, 2009

Conditions
Uveitis, PosteriorUveitis, IntermediatePanuveitis
Interventions
DRUG

Placebo

PO BID

DRUG

LX211

0.2 mg/kg, twice a day (BID)

DRUG

LX211

0.4 mg/kg, twice a day (BID)

DRUG

LX211

0.6 mg/kg, twice a day (BID)

Trial Locations (41)

10003

New York Eye & Ear Hospital, New York

21287

Wilmer Eye Institute, Baltimore

23502

Viginia Eye Consultants, Norfolk

35233

University of Alabama at Birmingham, Birmingham

46280

Midwest Eye Institute, Indianapolis

49546

Associated Retinal Consultants, PC, Grand Rapids

60612

University of Illinois - Chicago, Chicago

64111

Tauber Eye Center, Kansas City

75231

Texas Retina Associates, Dallas

76012

Texas Retina Associates, Arlington

77030

Vitreoretinal Consultants, Houston

78240

Retina & Uveitis Consultants of Texas, San Antonio

78705

Retina Research Center, Austin

85014

Retinal Consultants of Arizona, Phoenix

97201

Oregon Health Sciences University, Portland

02114

Massachusetts Eye and Ear Infirmary, Boston

02142

Massachusetts Eye Research and Surgery Institute, Cambridge

07103

UMDNJ-New Jersey Medical School, Ophthalmology Dept., Newark

Unknown

Duke University Eye Center, Erwin Road, Durham

Universitätsklinik für Augenheilkunde, Salzburg

Klinik für Augenheilkunde, Dept. of Ophthalmology, Vienna

Center Hospitalier Universitaire d' Angers, Service d'Opthalmologie, Angers

Hôpital Pitié Salpétrière, Service d'Ophtalmologie, Paris

Universitätsklinikum Freiburg, Freiburg im Breisgau

Augenklinik der Universität Heidelberg, Heidelberg

Universitätsklinikum Tübingen, Tübingen

L V Prasad Eye Institute, Hyderabaad

Consultant, Retina and Vitreous Services, Bhubaneswar L V Prasad Eye Institute, Bhubaneswar

Department of Opthalmology, Sankara Nethralaya, Medical Research Foundation,, Chennai

Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology, Madurai

Vittala International Institute of Ophthalmology, Bangalore

Advanced Eye Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh

Aravind Eye Hospital, Uvea Clinic, Coimbatore

Aditya Jyot Eye Hospital Pvt Ltd, Mumbai

Dr. R. P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi

Bristol Eye Hospital and University of Bristol, Bristol

Royal Liverpool University Hospital, Liverpool

Moorfields Eye Hospital, London

N6A 4G5

Ivey Eye Institute, London

K1H 8L6

University of Ottawa Eye Institute, Ottawa

H3A 1A1

McGill University Health Center, Montreal

Sponsors
All Listed Sponsors
lead

Lux Biosciences, Inc.

INDUSTRY